Skip to main content
Journal ArticleOPEN ACCESS

Case Report of Transverse Myelitis in a Patient Receiving Etanercept for Rheumatoid Arthritis

  • Defty H
  • Sames E
  • Doherty T
  • et al.
Case Reports in Rheumatology (2013) 2013 1-2
DOI: 10.1155/2013/728371
N/ACitations
Citations of this article
7Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Etanercept is a monoclonal antibody targeted against Tumour Necrosis Factor-alpha (TNF-a) which is an effective treatment for rheumatoid arthritis and is in cases where conventional disease modifying agents such as methotrexate have failed. Neurological complications of treatment have been documented. We describe a case of transverse myelitis occurring in a 48 year-old lady with RA since 1994 who had been receiving etanercept for four years.

Cite

CITATION STYLE

APA

Defty, H., Sames, E., Doherty, T., & Hughes, R. (2013). Case Report of Transverse Myelitis in a Patient Receiving Etanercept for Rheumatoid Arthritis. Case Reports in Rheumatology, 2013, 1–2. https://doi.org/10.1155/2013/728371

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free